This afternoon the agencies issued additional ACA guidance in the form of frequently asked questions. This twelfth set of frequently asked questions addresses a number of issues under the preventive care contraceptive requirement. This requirement only applies to non-grandfathered plans.The guidance confirms that all FDA-approved contraceptives must be provided without cost sharing under the preventive care requirement, not just oral contraceptives as some have suggested. But, more importantly, the guidance also addresses the generic and brand-name drug question with respect to contraceptives. In this regard, the guidance provides that plans may cover a generic contraceptive drug without cost-sharing and impose the regular cost-sharing for branded contraceptive drugs, but with an important caveat. In that case, a plan must accommodate any individual for whom the generic drug (or a brand name drug) would be medically inappropriate, as determined by the individual’s health care provider, by having a mechanism for waiving the otherwise applicable cost-sharing for the branded or non-preferred brand version. Further, if a generic version is not available, or would not be medically appropriate for the patient, then a plan must provide coverage for the brand name drug without cost sharing. The full version of the guidance can be accessed here.
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.